Eczema epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(9 intermediate revisions by 3 users not shown)
Line 4: Line 4:


==Overview==
==Overview==
In the United States, [[eczema]] has a [[prevalence]] of 10.7% in children and 7.2% in adults. <ref name="pmiddoi: 10.1038/jid.2010.251.">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=doi: 10.1038/jid.2010.251. | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10 }} </ref><ref name="pmiddoi: 10.1038/jid.2014.325.">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=doi: 10.1038/jid.2014.325. | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10 }} </ref> [[Eczema]] has more predilection in [[males]]. <ref name="pmid17498413">{{cite journal| author=Hanifin JM, Reed ML, Eczema Prevalence and Impact Working Group| title=A population-based survey of eczema prevalence in the United States. | journal=Dermatitis | year= 2007 | volume= 18 | issue= 2 | pages= 82-91 | pmid=17498413 | doi=10.2310/6620.2007.06034 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17498413  }} </ref>
In the United States, [[eczema]] has a [[prevalence]] of 10.7% in children and 7.2% in adults. <ref name="pmid20739951">{{cite journal| author=Shaw TE, Currie GP, Koudelka CW, Simpson EL| title=Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. | journal=J Invest Dermatol | year= 2011 | volume= 131 | issue= 1 | pages= 67-73 | pmid=20739951 | doi=10.1038/jid.2010.251 | pmc=3130508 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20739951 }} </ref> <ref name="pmid25078665">{{cite journal| author=Silverberg JI, Garg NK, Paller AS, Fishbein AB, Zee PC| title=Sleep disturbances in adults with eczema are associated with impaired overall health: a US population-based study. | journal=J Invest Dermatol | year= 2015 | volume= 135 | issue= 1 | pages= 56-66 | pmid=25078665 | doi=10.1038/jid.2014.325 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25078665 }} </ref> [[Eczema]] has more predilection in [[males]]. <ref name="pmid17498413">{{cite journal| author=Hanifin JM, Reed ML, Eczema Prevalence and Impact Working Group| title=A population-based survey of eczema prevalence in the United States. | journal=Dermatitis | year= 2007 | volume= 18 | issue= 2 | pages= 82-91 | pmid=17498413 | doi=10.2310/6620.2007.06034 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17498413  }} </ref>


==Eczema Epidemiology and Demographics==
==Eczema Epidemiology and Demographics==
*A recent study showed that persistence of [[disease]] 8 years from the [[onset]] is noted in 20% of [[children]].<ref name="pmiddoi: 10.1016/j.jaad.2016.05.028.">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=doi: 10.1016/j.jaad.2016.05.028. | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10 }} </ref>
*A recent study showed that persistence of [[disease]] 8 years from the [[onset]] is noted in 20% of [[children]].<ref name="pmid27544489">{{cite journal| author=Kim JP, Chao LX, Simpson EL, Silverberg JI| title=Persistence of atopic dermatitis (AD): A systematic review and meta-analysis. | journal=J Am Acad Dermatol | year= 2016 | volume= 75 | issue= 4 | pages= 681-687.e11 | pmid=27544489 | doi=10.1016/j.jaad.2016.05.028 | pmc=5216177 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27544489 }} </ref>
* [[Eczema]] has more predilection in [[males]]. <ref name="pmid17498413">{{cite journal| author=Hanifin JM, Reed ML, Eczema Prevalence and Impact Working Group| title=A population-based survey of eczema prevalence in the United States. | journal=Dermatitis | year= 2007 | volume= 18 | issue= 2 | pages= 82-91 | pmid=17498413 | doi=10.2310/6620.2007.06034 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17498413  }} </ref>
* [[Eczema]] has more predilection in [[males]]. <ref name="pmid17498413">{{cite journal| author=Hanifin JM, Reed ML, Eczema Prevalence and Impact Working Group| title=A population-based survey of eczema prevalence in the United States. | journal=Dermatitis | year= 2007 | volume= 18 | issue= 2 | pages= 82-91 | pmid=17498413 | doi=10.2310/6620.2007.06034 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17498413  }} </ref>
In the United States, [[eczema]] has a [[prevalence]] of 10.7% in children and 7.2% in adults. <ref name="pmiddoi: 10.1038/jid.2010.251.">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=doi: 10.1038/jid.2010.251. | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10 }} </ref><ref name="pmiddoi: 10.1038/jid.2014.325.">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=doi: 10.1038/jid.2014.325. | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10 }} </ref> [[Eczema]] has more predilection in [[males]]. <ref name="pmid17498413">{{cite journal| author=Hanifin JM, Reed ML, Eczema Prevalence and Impact Working Group| title=A population-based survey of eczema prevalence in the United States. | journal=Dermatitis | year= 2007 | volume= 18 | issue= 2 | pages= 82-91 | pmid=17498413 | doi=10.2310/6620.2007.06034 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17498413 }} </ref>
*In the United States, [[eczema]] has a [[prevalence]] of 10.7% in children and 7.2% in adults. <ref name="pmid20739951">{{cite journal| author=Shaw TE, Currie GP, Koudelka CW, Simpson EL| title=Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. | journal=J Invest Dermatol | year= 2011 | volume= 131 | issue= 1 | pages= 67-73 | pmid=20739951 | doi=10.1038/jid.2010.251 | pmc=3130508 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20739951 }} </ref> <ref name="pmid25078665">{{cite journal| author=Silverberg JI, Garg NK, Paller AS, Fishbein AB, Zee PC| title=Sleep disturbances in adults with eczema are associated with impaired overall health: a US population-based study. | journal=J Invest Dermatol | year= 2015 | volume= 135 | issue= 1 | pages= 56-66 | pmid=25078665 | doi=10.1038/jid.2014.325 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25078665 }} </ref>
* [[Prevalence]] of [[eczema]] has plateaued in high-income countries, with low- and middle-income countries still having increasing cases. <ref name="pmid29421277">{{cite journal| author=Baurecht H, Rühlemann MC, Rodríguez E, Thielking F, Harder I, Erkens AS | display-authors=etal| title=Epidermal lipid composition, barrier integrity, and eczematous inflammation are associated with skin microbiome configuration. | journal=J Allergy Clin Immunol | year= 2018 | volume= 141 | issue= 5 | pages= 1668-1676.e16 | pmid=29421277 | doi=10.1016/j.jaci.2018.01.019 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29421277 }} </ref>


==References==
==References==
Line 15: Line 16:
{{Reflist|2}}
{{Reflist|2}}


[[Category:Needs content]]
[[category:Up to Date]]

Latest revision as of 18:20, 14 July 2022

Eczema Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Eczema from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Social Impact

Future or Investigational Therapies

Case Studies

Case #1

Eczema On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Eczema

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Eczema

CDC on Eczema

Eczema in the news

Blogs on Eczema

Directions to Hospitals Treating Eczema

Risk calculators and risk factors for Eczema

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.

Overview

In the United States, eczema has a prevalence of 10.7% in children and 7.2% in adults. [1] [2] Eczema has more predilection in males. [3]

Eczema Epidemiology and Demographics

References

  1. 1.0 1.1 Shaw TE, Currie GP, Koudelka CW, Simpson EL (2011). "Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health". J Invest Dermatol. 131 (1): 67–73. doi:10.1038/jid.2010.251. PMC 3130508. PMID 20739951.
  2. 2.0 2.1 Silverberg JI, Garg NK, Paller AS, Fishbein AB, Zee PC (2015). "Sleep disturbances in adults with eczema are associated with impaired overall health: a US population-based study". J Invest Dermatol. 135 (1): 56–66. doi:10.1038/jid.2014.325. PMID 25078665.
  3. 3.0 3.1 Hanifin JM, Reed ML, Eczema Prevalence and Impact Working Group (2007). "A population-based survey of eczema prevalence in the United States". Dermatitis. 18 (2): 82–91. doi:10.2310/6620.2007.06034. PMID 17498413.
  4. Kim JP, Chao LX, Simpson EL, Silverberg JI (2016). "Persistence of atopic dermatitis (AD): A systematic review and meta-analysis". J Am Acad Dermatol. 75 (4): 681–687.e11. doi:10.1016/j.jaad.2016.05.028. PMC 5216177. PMID 27544489.
  5. Baurecht H, Rühlemann MC, Rodríguez E, Thielking F, Harder I, Erkens AS; et al. (2018). "Epidermal lipid composition, barrier integrity, and eczematous inflammation are associated with skin microbiome configuration". J Allergy Clin Immunol. 141 (5): 1668–1676.e16. doi:10.1016/j.jaci.2018.01.019. PMID 29421277.